Additions to Philippine Slender Skinks of the <i>Brachymeles bonitae </i>Complex (Reptilia: Squamata: Scincidae) I:a new species from Lubang Island

Geheber, Aaron D., Davis, Drew R., Watters, Jessa L., Penrod, Michelle L., Feller, Kathryn D., Davey, Conner S., Ellsworth, Elyse D., Flanagan, Rachel L., Heitz, Brendan B., Moore, Tana, Nguyen, Marie D. C., Roberts, Austyn, Sutton, John, Sanguila, Marites B., Linkem, Charles W., Brown, Rafe M., Siler, Cameron D. (2016): Additions to Philippine Slender Skinks of the Brachymeles bonitae Complex (Reptilia: Squamata: Scincidae) I: a new species from Lubang Island. Zootaxa 4132 (1): 1-14, DOI: http://doi.org/10.11646/zootaxa.4132.1.

The biggest “Have” of them all: Wal-Mart and its litigation outcomes in slip-and-fall cases

Scholars have theorized that resource-rich litigants known as the “haves” tend to succeed disproportionately in litigation when the adverse party is a “have-not.” The traditional theory suggests that haves are able to use their wealth to secure better attorney representation and can use their frequent experience in litigation to tip the scales of justice in their favor, particularly when faced with “one-shotters” whose involvement in litigation is infrequent. A remaining question, however, is whether some haves fare better than other similarly situated haves. Specifically, this article posits that the litigation strategy used by the defendant may also play a role in litigation outcomes. Companies that tenaciously fight claims that, in the short term, would be cheaper to settle might discourage otherwise valid claims in the future from being filed out of fear that the litigation will be a protracted battle. This article examines Wal-Mart Stores, Inc. (Wal-Mart)—the largest revenue-generating company in the United States—to explore whether it fares better than other resource-rich defendants. Wal-Mart in particular has a reputation against settling cases and thus is an excellent vehicle to investigate this hypothesis. Appellate cases in an eleven-year period involving slip-and-fall litigation were compiled, and the results show that Wal-Mart did win at a higher rate than other defendants. Although more research is needed to explore fully the effect of litigation strategy on win–loss rates, this sample of cases demonstrates that Wal-Mart is a more effective and victorious litigant.Journal ArticlePublishe

Empowerment or limitation?: A critical exploration of American state women‑owned business programs

Governments have a history of intervention in the market to aid small, minority, and women-owned businesses. This research explores women-owned business development programs across the United States. The paper begins with a discussion of programs to serve women-owned businesses, noting barriers that exist for women business owners to access markets and capital. Analysis considers program offerings and how they are communicated to the public and client businesses via government websites. Policy approaches may reinforce patterns of suppression, rather than opening maximum opportunities for women business owners.Journal ArticleFinal article publishe

An Open-Label Pilot Study of Acetylcholinesterase Inhibitors to Promote Functional Recovery in Elderly Cognitively Impaired Stroke Patients

have different pharmacologic profiles, they were examined separately. Results: Forty participants started study medica-tion; 14 participants terminated prematurely. Donepezil-treated participants experienced a 14-point greater im-provement in the FIM-motor score compared to either galantamine-treated participants or the historical compara-tor group (repeated measures mixed model, group ! time interaction p ! 0.0001). Change in apathy, but not in cogni-tion, was also associated with change in the FIM-motor score. Conclusions: In this open-label study, participants receiving donepezil had better functional recovery than participants receiving galantamine or the historical comparators. This im-provement may reflect efficacy at the starting dose for done-pezil but not galantamine. A randomized trial is in progress. Copyright © 2008 S. Karger AG, Basel Key Word